Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Non-Current Debt (2019)

Avidity Biosciences (RNA) has disclosed Non-Current Debt for 1 consecutive years, with $1.8 million as the latest value for Q4 2019.

  • For the quarter ending Q4 2019, Non-Current Debt changed N/A year-over-year to $1.8 million, compared with a TTM value of $1.8 million through Dec 2019, changed N/A, and an annual FY2019 reading of $1.8 million, changed N/A over the prior year.
  • Non-Current Debt was $1.8 million for Q4 2019 at Avidity Biosciences.
  • Across five years, Non-Current Debt topped out at $1.8 million in Q4 2019 and bottomed at $1.8 million in Q4 2019.